Prevalence and staging of chronic kidney disease in renal transplant recipients
: Introduction: Diagnosis and staging of chronic kidney disease (CKD) is important for management and prevention of renal disease progression. It is unclear whether K/DOQI guidelines of the National Kidney Foundation are applicable to diagnosis of CKD in renal transplant recipients (RTRs) and whic...
Gespeichert in:
Veröffentlicht in: | Clinical transplantation 2009-09, Vol.23 (5), p.628-636 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 636 |
---|---|
container_issue | 5 |
container_start_page | 628 |
container_title | Clinical transplantation |
container_volume | 23 |
creator | Costa de Oliveira, Cláudia Maria Mota, Márcia Uchoa Mota, Rosa Salani Nóbrega, Joana Oliveira Melo, Débora Silva Vieira, Ariane Sá Fernandes, Paula Frassinetti Castelo Branco Campos, Henry de Holanda Evangelista Jr, João Batista |
description | : Introduction: Diagnosis and staging of chronic kidney disease (CKD) is important for management and prevention of renal disease progression. It is unclear whether K/DOQI guidelines of the National Kidney Foundation are applicable to diagnosis of CKD in renal transplant recipients (RTRs) and which method is most appropriate for estimating glomerular filtration.
Objectives: To determine the prevalence and staging of CKD in RTRs, according to K/DOQI guidelines, and the prevalence of complications of CKD.
Subjects and methods: This cross‐sectional study included RTRs at least six months post‐transplantation followed at a single out‐patient service. The glomerular filtration rate (GFR) was estimated with two different equations: the MDRD equation (Modification of Diet in Renal Disease) with four variables (age, creatinine level, gender, and race) and the Cockcroft–Gault (CG) formula. Patients with GFR more than 60 mL/min/1.73 m2 were diagnosed with CKD only in the presence of renal damage (hematuria, proteinuria, or evidence of injury in renal biopsy). CKD staging was compared to the two equations and the prevalence of complications was determined.
Results: The study evaluated 241 RTRs (average age: 40.6 ± 12.5 yr, 62.2% male; 4.5% black, 50.6% from cadaveric donors). Average follow‐up time was 6.8 ± 6.1 yr and the average baseline creatinine level was 1.48 ± 0.72 mg/dL. CKD was diagnosed in 70.5% of RTRs, of whom 52.9% (MDRD)/47.6% (CG) were classified as Stage III (GFR: 30–59 mL/min/1.73 m2). The agreement between the two methods was very close with regard to CKD diagnosis (κ = 0.92) and close for stage‐dependent prevalence (κ = 0.68). The prevalence of anemia, hypocalcemia, hyperphosphatemia (HF), hyperuricemia (HU), and systemic arterial hypertension (SAH) was 10.6%, 7.6%, 10.3%, 54%, and 73.4% for patients with CKD. Significant differences were observed for HU, HF and SAH in patients without CKD. Anemia, HU and SAH were associated with CKD stage (p |
doi_str_mv | 10.1111/j.1399-0012.2009.01023.x |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_734070132</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>734070132</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4863-64655e3bcda0e7ea542bfb87622695260a5b89197938d4cc6d9973f1af2da8b83</originalsourceid><addsrcrecordid>eNqNkEtvEzEURi1ERUPhLyBvEKuZ-jHjx4IFipqCFLUFFXVpeTx3itOJJ9gTSP59PSRKt3jjq-vz2dcHIUxJSfO6XJWUa10QQlnJCNEloYTxcvcKzU4Hr9GMaMJyLfg5epvSKncFFfUbdE51LXilqhm6vYvwx_YQHGAbWpxG--jDIx467H7FIXiHn3wbYI9bn8AmwD7gCMH2eIw2pE1vw5gbzm88hDG9Q2ed7RO8P-4X6Ofi6n7-tVjeXn-bf1kWrlKCF6ISdQ28ca0lIMHWFWu6RknBmNA1E8TWjdJUS81VWzknWq0l76jtWGtVo_gF-nS4dxOH31tIo1n75KDP48CwTUbyikhCOcukOpAuDilF6Mwm-rWNe0OJmWyalZmkmUmamWyafzbNLkc_HB_ZNmtoX4JHfRn4eARscrbvshHn04ljVKv80Wnazwfur-9h_98DmPn9j6nK-eKQ92mE3Slv45MRksvaPNxcm-_VYvEglTBL_gyQOJ7J</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>734070132</pqid></control><display><type>article</type><title>Prevalence and staging of chronic kidney disease in renal transplant recipients</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Costa de Oliveira, Cláudia Maria ; Mota, Márcia Uchoa ; Mota, Rosa Salani ; Nóbrega, Joana Oliveira ; Melo, Débora Silva ; Vieira, Ariane Sá ; Fernandes, Paula Frassinetti Castelo Branco ; Campos, Henry de Holanda ; Evangelista Jr, João Batista</creator><creatorcontrib>Costa de Oliveira, Cláudia Maria ; Mota, Márcia Uchoa ; Mota, Rosa Salani ; Nóbrega, Joana Oliveira ; Melo, Débora Silva ; Vieira, Ariane Sá ; Fernandes, Paula Frassinetti Castelo Branco ; Campos, Henry de Holanda ; Evangelista Jr, João Batista</creatorcontrib><description>: Introduction: Diagnosis and staging of chronic kidney disease (CKD) is important for management and prevention of renal disease progression. It is unclear whether K/DOQI guidelines of the National Kidney Foundation are applicable to diagnosis of CKD in renal transplant recipients (RTRs) and which method is most appropriate for estimating glomerular filtration.
Objectives: To determine the prevalence and staging of CKD in RTRs, according to K/DOQI guidelines, and the prevalence of complications of CKD.
Subjects and methods: This cross‐sectional study included RTRs at least six months post‐transplantation followed at a single out‐patient service. The glomerular filtration rate (GFR) was estimated with two different equations: the MDRD equation (Modification of Diet in Renal Disease) with four variables (age, creatinine level, gender, and race) and the Cockcroft–Gault (CG) formula. Patients with GFR more than 60 mL/min/1.73 m2 were diagnosed with CKD only in the presence of renal damage (hematuria, proteinuria, or evidence of injury in renal biopsy). CKD staging was compared to the two equations and the prevalence of complications was determined.
Results: The study evaluated 241 RTRs (average age: 40.6 ± 12.5 yr, 62.2% male; 4.5% black, 50.6% from cadaveric donors). Average follow‐up time was 6.8 ± 6.1 yr and the average baseline creatinine level was 1.48 ± 0.72 mg/dL. CKD was diagnosed in 70.5% of RTRs, of whom 52.9% (MDRD)/47.6% (CG) were classified as Stage III (GFR: 30–59 mL/min/1.73 m2). The agreement between the two methods was very close with regard to CKD diagnosis (κ = 0.92) and close for stage‐dependent prevalence (κ = 0.68). The prevalence of anemia, hypocalcemia, hyperphosphatemia (HF), hyperuricemia (HU), and systemic arterial hypertension (SAH) was 10.6%, 7.6%, 10.3%, 54%, and 73.4% for patients with CKD. Significant differences were observed for HU, HF and SAH in patients without CKD. Anemia, HU and SAH were associated with CKD stage (p < 0.001).
Conclusion: The prevalence of CKD in the study population was high (70.5%). The two equations tested correlated closely when used for GFR estimation. Routine CKD staging in RTRs would provide patients with safer and more appropriate management.</description><identifier>ISSN: 0902-0063</identifier><identifier>EISSN: 1399-0012</identifier><identifier>DOI: 10.1111/j.1399-0012.2009.01023.x</identifier><identifier>PMID: 19563484</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Adult ; Biological and medical sciences ; chronic kidney disease ; Cockcroft-Gault ; Cross-Sectional Studies ; Epidemiology ; Female ; Fundamental and applied biological sciences. Psychology ; Fundamental immunology ; General aspects ; Glomerular Filtration Rate ; Humans ; Kidney Failure, Chronic - classification ; Kidney Failure, Chronic - epidemiology ; Kidney Transplantation - statistics & numerical data ; Male ; MDRD equation ; Medical sciences ; Prevalence ; Prognosis ; Public health. Hygiene ; Public health. Hygiene-occupational medicine ; renal transplantaion ; serum creatinine ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; Tissue, organ and graft immunology ; Treatment Outcome</subject><ispartof>Clinical transplantation, 2009-09, Vol.23 (5), p.628-636</ispartof><rights>2009 John Wiley & Sons A/S</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4863-64655e3bcda0e7ea542bfb87622695260a5b89197938d4cc6d9973f1af2da8b83</citedby><cites>FETCH-LOGICAL-c4863-64655e3bcda0e7ea542bfb87622695260a5b89197938d4cc6d9973f1af2da8b83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1399-0012.2009.01023.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1399-0012.2009.01023.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21984658$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19563484$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Costa de Oliveira, Cláudia Maria</creatorcontrib><creatorcontrib>Mota, Márcia Uchoa</creatorcontrib><creatorcontrib>Mota, Rosa Salani</creatorcontrib><creatorcontrib>Nóbrega, Joana Oliveira</creatorcontrib><creatorcontrib>Melo, Débora Silva</creatorcontrib><creatorcontrib>Vieira, Ariane Sá</creatorcontrib><creatorcontrib>Fernandes, Paula Frassinetti Castelo Branco</creatorcontrib><creatorcontrib>Campos, Henry de Holanda</creatorcontrib><creatorcontrib>Evangelista Jr, João Batista</creatorcontrib><title>Prevalence and staging of chronic kidney disease in renal transplant recipients</title><title>Clinical transplantation</title><addtitle>Clin Transplant</addtitle><description>: Introduction: Diagnosis and staging of chronic kidney disease (CKD) is important for management and prevention of renal disease progression. It is unclear whether K/DOQI guidelines of the National Kidney Foundation are applicable to diagnosis of CKD in renal transplant recipients (RTRs) and which method is most appropriate for estimating glomerular filtration.
Objectives: To determine the prevalence and staging of CKD in RTRs, according to K/DOQI guidelines, and the prevalence of complications of CKD.
Subjects and methods: This cross‐sectional study included RTRs at least six months post‐transplantation followed at a single out‐patient service. The glomerular filtration rate (GFR) was estimated with two different equations: the MDRD equation (Modification of Diet in Renal Disease) with four variables (age, creatinine level, gender, and race) and the Cockcroft–Gault (CG) formula. Patients with GFR more than 60 mL/min/1.73 m2 were diagnosed with CKD only in the presence of renal damage (hematuria, proteinuria, or evidence of injury in renal biopsy). CKD staging was compared to the two equations and the prevalence of complications was determined.
Results: The study evaluated 241 RTRs (average age: 40.6 ± 12.5 yr, 62.2% male; 4.5% black, 50.6% from cadaveric donors). Average follow‐up time was 6.8 ± 6.1 yr and the average baseline creatinine level was 1.48 ± 0.72 mg/dL. CKD was diagnosed in 70.5% of RTRs, of whom 52.9% (MDRD)/47.6% (CG) were classified as Stage III (GFR: 30–59 mL/min/1.73 m2). The agreement between the two methods was very close with regard to CKD diagnosis (κ = 0.92) and close for stage‐dependent prevalence (κ = 0.68). The prevalence of anemia, hypocalcemia, hyperphosphatemia (HF), hyperuricemia (HU), and systemic arterial hypertension (SAH) was 10.6%, 7.6%, 10.3%, 54%, and 73.4% for patients with CKD. Significant differences were observed for HU, HF and SAH in patients without CKD. Anemia, HU and SAH were associated with CKD stage (p < 0.001).
Conclusion: The prevalence of CKD in the study population was high (70.5%). The two equations tested correlated closely when used for GFR estimation. Routine CKD staging in RTRs would provide patients with safer and more appropriate management.</description><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>chronic kidney disease</subject><subject>Cockcroft-Gault</subject><subject>Cross-Sectional Studies</subject><subject>Epidemiology</subject><subject>Female</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Fundamental immunology</subject><subject>General aspects</subject><subject>Glomerular Filtration Rate</subject><subject>Humans</subject><subject>Kidney Failure, Chronic - classification</subject><subject>Kidney Failure, Chronic - epidemiology</subject><subject>Kidney Transplantation - statistics & numerical data</subject><subject>Male</subject><subject>MDRD equation</subject><subject>Medical sciences</subject><subject>Prevalence</subject><subject>Prognosis</subject><subject>Public health. Hygiene</subject><subject>Public health. Hygiene-occupational medicine</subject><subject>renal transplantaion</subject><subject>serum creatinine</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><subject>Tissue, organ and graft immunology</subject><subject>Treatment Outcome</subject><issn>0902-0063</issn><issn>1399-0012</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkEtvEzEURi1ERUPhLyBvEKuZ-jHjx4IFipqCFLUFFXVpeTx3itOJJ9gTSP59PSRKt3jjq-vz2dcHIUxJSfO6XJWUa10QQlnJCNEloYTxcvcKzU4Hr9GMaMJyLfg5epvSKncFFfUbdE51LXilqhm6vYvwx_YQHGAbWpxG--jDIx467H7FIXiHn3wbYI9bn8AmwD7gCMH2eIw2pE1vw5gbzm88hDG9Q2ed7RO8P-4X6Ofi6n7-tVjeXn-bf1kWrlKCF6ISdQ28ca0lIMHWFWu6RknBmNA1E8TWjdJUS81VWzknWq0l76jtWGtVo_gF-nS4dxOH31tIo1n75KDP48CwTUbyikhCOcukOpAuDilF6Mwm-rWNe0OJmWyalZmkmUmamWyafzbNLkc_HB_ZNmtoX4JHfRn4eARscrbvshHn04ljVKv80Wnazwfur-9h_98DmPn9j6nK-eKQ92mE3Slv45MRksvaPNxcm-_VYvEglTBL_gyQOJ7J</recordid><startdate>200909</startdate><enddate>200909</enddate><creator>Costa de Oliveira, Cláudia Maria</creator><creator>Mota, Márcia Uchoa</creator><creator>Mota, Rosa Salani</creator><creator>Nóbrega, Joana Oliveira</creator><creator>Melo, Débora Silva</creator><creator>Vieira, Ariane Sá</creator><creator>Fernandes, Paula Frassinetti Castelo Branco</creator><creator>Campos, Henry de Holanda</creator><creator>Evangelista Jr, João Batista</creator><general>Blackwell Publishing Ltd</general><general>Wiley</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200909</creationdate><title>Prevalence and staging of chronic kidney disease in renal transplant recipients</title><author>Costa de Oliveira, Cláudia Maria ; Mota, Márcia Uchoa ; Mota, Rosa Salani ; Nóbrega, Joana Oliveira ; Melo, Débora Silva ; Vieira, Ariane Sá ; Fernandes, Paula Frassinetti Castelo Branco ; Campos, Henry de Holanda ; Evangelista Jr, João Batista</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4863-64655e3bcda0e7ea542bfb87622695260a5b89197938d4cc6d9973f1af2da8b83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>chronic kidney disease</topic><topic>Cockcroft-Gault</topic><topic>Cross-Sectional Studies</topic><topic>Epidemiology</topic><topic>Female</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Fundamental immunology</topic><topic>General aspects</topic><topic>Glomerular Filtration Rate</topic><topic>Humans</topic><topic>Kidney Failure, Chronic - classification</topic><topic>Kidney Failure, Chronic - epidemiology</topic><topic>Kidney Transplantation - statistics & numerical data</topic><topic>Male</topic><topic>MDRD equation</topic><topic>Medical sciences</topic><topic>Prevalence</topic><topic>Prognosis</topic><topic>Public health. Hygiene</topic><topic>Public health. Hygiene-occupational medicine</topic><topic>renal transplantaion</topic><topic>serum creatinine</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><topic>Tissue, organ and graft immunology</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Costa de Oliveira, Cláudia Maria</creatorcontrib><creatorcontrib>Mota, Márcia Uchoa</creatorcontrib><creatorcontrib>Mota, Rosa Salani</creatorcontrib><creatorcontrib>Nóbrega, Joana Oliveira</creatorcontrib><creatorcontrib>Melo, Débora Silva</creatorcontrib><creatorcontrib>Vieira, Ariane Sá</creatorcontrib><creatorcontrib>Fernandes, Paula Frassinetti Castelo Branco</creatorcontrib><creatorcontrib>Campos, Henry de Holanda</creatorcontrib><creatorcontrib>Evangelista Jr, João Batista</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical transplantation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Costa de Oliveira, Cláudia Maria</au><au>Mota, Márcia Uchoa</au><au>Mota, Rosa Salani</au><au>Nóbrega, Joana Oliveira</au><au>Melo, Débora Silva</au><au>Vieira, Ariane Sá</au><au>Fernandes, Paula Frassinetti Castelo Branco</au><au>Campos, Henry de Holanda</au><au>Evangelista Jr, João Batista</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prevalence and staging of chronic kidney disease in renal transplant recipients</atitle><jtitle>Clinical transplantation</jtitle><addtitle>Clin Transplant</addtitle><date>2009-09</date><risdate>2009</risdate><volume>23</volume><issue>5</issue><spage>628</spage><epage>636</epage><pages>628-636</pages><issn>0902-0063</issn><eissn>1399-0012</eissn><abstract>: Introduction: Diagnosis and staging of chronic kidney disease (CKD) is important for management and prevention of renal disease progression. It is unclear whether K/DOQI guidelines of the National Kidney Foundation are applicable to diagnosis of CKD in renal transplant recipients (RTRs) and which method is most appropriate for estimating glomerular filtration.
Objectives: To determine the prevalence and staging of CKD in RTRs, according to K/DOQI guidelines, and the prevalence of complications of CKD.
Subjects and methods: This cross‐sectional study included RTRs at least six months post‐transplantation followed at a single out‐patient service. The glomerular filtration rate (GFR) was estimated with two different equations: the MDRD equation (Modification of Diet in Renal Disease) with four variables (age, creatinine level, gender, and race) and the Cockcroft–Gault (CG) formula. Patients with GFR more than 60 mL/min/1.73 m2 were diagnosed with CKD only in the presence of renal damage (hematuria, proteinuria, or evidence of injury in renal biopsy). CKD staging was compared to the two equations and the prevalence of complications was determined.
Results: The study evaluated 241 RTRs (average age: 40.6 ± 12.5 yr, 62.2% male; 4.5% black, 50.6% from cadaveric donors). Average follow‐up time was 6.8 ± 6.1 yr and the average baseline creatinine level was 1.48 ± 0.72 mg/dL. CKD was diagnosed in 70.5% of RTRs, of whom 52.9% (MDRD)/47.6% (CG) were classified as Stage III (GFR: 30–59 mL/min/1.73 m2). The agreement between the two methods was very close with regard to CKD diagnosis (κ = 0.92) and close for stage‐dependent prevalence (κ = 0.68). The prevalence of anemia, hypocalcemia, hyperphosphatemia (HF), hyperuricemia (HU), and systemic arterial hypertension (SAH) was 10.6%, 7.6%, 10.3%, 54%, and 73.4% for patients with CKD. Significant differences were observed for HU, HF and SAH in patients without CKD. Anemia, HU and SAH were associated with CKD stage (p < 0.001).
Conclusion: The prevalence of CKD in the study population was high (70.5%). The two equations tested correlated closely when used for GFR estimation. Routine CKD staging in RTRs would provide patients with safer and more appropriate management.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>19563484</pmid><doi>10.1111/j.1399-0012.2009.01023.x</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0902-0063 |
ispartof | Clinical transplantation, 2009-09, Vol.23 (5), p.628-636 |
issn | 0902-0063 1399-0012 |
language | eng |
recordid | cdi_proquest_miscellaneous_734070132 |
source | MEDLINE; Access via Wiley Online Library |
subjects | Adult Biological and medical sciences chronic kidney disease Cockcroft-Gault Cross-Sectional Studies Epidemiology Female Fundamental and applied biological sciences. Psychology Fundamental immunology General aspects Glomerular Filtration Rate Humans Kidney Failure, Chronic - classification Kidney Failure, Chronic - epidemiology Kidney Transplantation - statistics & numerical data Male MDRD equation Medical sciences Prevalence Prognosis Public health. Hygiene Public health. Hygiene-occupational medicine renal transplantaion serum creatinine Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases Tissue, organ and graft immunology Treatment Outcome |
title | Prevalence and staging of chronic kidney disease in renal transplant recipients |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T17%3A00%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prevalence%20and%20staging%20of%20chronic%20kidney%20disease%20in%20renal%20transplant%20recipients&rft.jtitle=Clinical%20transplantation&rft.au=Costa%20de%20Oliveira,%20Cl%C3%A1udia%20Maria&rft.date=2009-09&rft.volume=23&rft.issue=5&rft.spage=628&rft.epage=636&rft.pages=628-636&rft.issn=0902-0063&rft.eissn=1399-0012&rft_id=info:doi/10.1111/j.1399-0012.2009.01023.x&rft_dat=%3Cproquest_cross%3E734070132%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=734070132&rft_id=info:pmid/19563484&rfr_iscdi=true |